Black Diamond Therapeutics

BDTX · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 11 days ago

Previous year: -$0.35

-385.7%

Weighted average common shares outstanding - diluted

57.67M

Previous year: 51.81M

+11.3%

Research and development expenses

$10.5M

Previous year: $13.5M

-22.4%

General and administrative expenses

$4.96M

Previous year: $6.7M

-25.9%

Loading...

Black Diamond Therapeutics

Unlock previous datapoints

Upgrade

Black Diamond Therapeutics

Unlock previous datapoints

Upgrade

Black Diamond Therapeutics Revenue by Segment

Revenue by Segment

License Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$116M

P/E Ratio

24.97

Sector

N/A

Industry

N/A

52-Week High

$4.86

52-Week Low

$1.23

Weighted average common shares outstanding - diluted

57.67M

Research and development expenses

$10.5M

General and administrative expenses

$4.96M

Total operating expenses

$15.5M

Interest income

$595K

Products

Get in Touch

Resources

Black Diamond Therapeutics

Black Diamond Therapeutics

Black Diamond Therapeutics

Black Diamond Therapeutics Revenue by Segment

Revenue by Segment

License Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics